Difficulty: Medium
Average Score: 92%
Practice
Which of the following drugs or drug groups is not useful in the prevention of nausea and vomiting included by cancer chemotherapy?
Correct answer
C
Rationale
In the context of ABVD chemotherapy drugs, the correct answer is C) Ketaserin, as it is not typically used in the prevention of nausea and vomiting induced by cancer chemotherapy. Ketaserin is a serotonin receptor antagonist primarily used for other medical purposes and is not a standard antiemetic drug for chemotherapy-induced nausea and vomiting.
A) Dexamethasone is a glucocorticoid commonly used to prevent chemotherapy-induced nausea and vomiting by reducing inflammation and suppressing the immune response.
B) Dronabinol, a synthetic form of THC, is used to stimulate appetite and reduce nausea and vomiting in patients undergoing chemotherapy.
D) Ondansetron is a selective serotonin 5-HT3 receptor antagonist that is highly effective in preventing chemotherapy-induced nausea and vomiting by blocking serotonin receptors in the central and peripheral nervous systems.
Educationally, understanding the mechanisms of action and appropriate use of antiemetic drugs in cancer chemotherapy is crucial for healthcare professionals to provide optimal supportive care to cancer patients. It is important to differentiate between drugs that are effective in managing chemotherapy-induced nausea and vomiting and those that are not indicated for this specific purpose to ensure patient comfort and treatment adherence.
A) Dexamethasone is a glucocorticoid commonly used to prevent chemotherapy-induced nausea and vomiting by reducing inflammation and suppressing the immune response.
B) Dronabinol, a synthetic form of THC, is used to stimulate appetite and reduce nausea and vomiting in patients undergoing chemotherapy.
D) Ondansetron is a selective serotonin 5-HT3 receptor antagonist that is highly effective in preventing chemotherapy-induced nausea and vomiting by blocking serotonin receptors in the central and peripheral nervous systems.
Educationally, understanding the mechanisms of action and appropriate use of antiemetic drugs in cancer chemotherapy is crucial for healthcare professionals to provide optimal supportive care to cancer patients. It is important to differentiate between drugs that are effective in managing chemotherapy-induced nausea and vomiting and those that are not indicated for this specific purpose to ensure patient comfort and treatment adherence.